The American Society of Clinical Oncology (ASCO) has issued the first-ever national safety standards for the administration of chemotherapy drugs. These chemotherapy administration safety standards were published in an early release of the Journal of Clinical Oncology.
Chemotherapy administration is complex and can have serious adverse effects, and the standardization of care can reduce the risk of errors, increase efficiency, and provide a framework for best practices. After a rigorous review process, the final list of chemotherapy administration safety standards consists of 31 standards covering topics such as selection of a chemotherapy regimen, treatment planning and informed consent, drug preparation, assessment of chemotherapy treatment compliance, and toxicity monitoring, among others.
These new chemotherapy standards were compiled by ASCO in conjunction with the Oncology Nursing Society (ONS). One of the ASCO and ONS recommendations calls for increased use of electronic medical record systems for chemotherapy administration as a way of improving safety and quality. According to the authors of the study, adherence to these 31 standards for safe chemotherapy administration should be a goal of all providers of adult cancer care.
Source:
J Clin Oncol. Published online ahead of print September 28, 2009.
Created on: 10/13/2009
Reviewed on: 10/13/2009
Add your comment